InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,124.40
(
-0.26%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.47
(
0.34%
)
Bitcoin
60,779.00
(
-1.67%
)
Post# of 1493
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TwoPack

Send PM Follow Ignore
Followers 3
Posts 83
Boards Moderated 0
Alias Born 07/17/2014

TwoPack

Re: None

Tuesday, 03/10/2015 9:52:00 AM

Tuesday, March 10, 2015 9:52:00 AM

Post# of 1493
While Novo Nordisk (NYSE:NVO) has not made an official announcement with regard to its already approved anti-obesity drug Saxenda, there seems to be anecdotal evidence that we are about to get some information regarding the launch. Up until now, the company has only stated that the launch will happen in the first half of 2015, and that about 500 sales reps would be assigned Saxenda duties.

SeekingAlpha 2015-03-10
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up